[WCN23_Free Paper]

Motor Neurone Disease

TREATMENT OUTCOMES FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS RECEIVING INTRAVENOUS EDARAVONE FROM A HOME AND ALTERNATIVE-SITE INFUSION PROVIDER 
Agessandro Abrahão (Canada)

THE GROWING DETECTION OF GENETIC VARIANTS OF UNCERTAIN SIGNIFICANCE IN AMYOTROPHIC LATERAL SCLEROSIS: WHAT IS THEIR SIGNIFICANCE FOR THE DISEASE ETIOPATHOGENESIS?
Anna D'Amico (Italy)

CORRELATION BETWEEN OCULOMETRIC MEASURES AND CLINICAL ASSESSMENT IN ALS PATIENTS PARTICIPATING IN A PHASE IIB CLINICAL DRUG TRIAL
Vivian E. Drory (Israel)

DEPRESSION, DISABILITY, AND COGNITIVE IMPAIRMENT AMONG ELDERS WITH ALZHEIMER'S IN NEPAL: THE FIRST STUDY
Nabina Sharma (Canada)

DETERMINANTS OF QUALITY OF LIFE IN LOCKED-IN AND COMPLETE LOCKED-IN ALS PATIENTS
Rossella Spataro (Italy)

EXPLORING ALS DIFFERENTIAL VULNERABILITY USING SINGLE-CELL TRANSCRIPTOMIC ANALYSIS
Paria Alipour (Canada)

NOVEL VRK 1 MUTATION IN A CASE OF PONTOCEREBELLAR HYPOPLASIA WITH DISTAL MOTOR AXONAL NEUROPATHY- FIRST CASE REPORT FROM INDIA
Rishikesh S. Joshi (India)